Creating a Common Platform for HIV Vaccine Research and HIV Care and Treatment Program

Second only to South Africa in HIV burden, Nigeria's complex epidemic of HIV viral subtypes is a vital target for HIV vaccine evaluation research. This grant will support a partnership between the Institute of Human Virology-Nigeria (IHV-Nigeria) - a not-for-profit indigenous research organization - and clinical research collaborators from the University of Ottawa to create an internationally certified HIV clinical research site capable of conducting HIV vaccine clinical trials. This will involve capacity building in clinical practice, research ethics, regulation, community mobilization, risk cohort development and clinical research, plus strengthening clinical laboratory facilities to the level of international certification. The idea is to achieve a fully functional clinical trials unit within a well engaged community and robust ethical and regulatory infrastructure.

Project ID

106356

Project status

Closed

Start Date

Thursday, September 30, 2010

End Date

Wednesday, December 31, 2014

Duration

41 months

IDRC Officer

Cohen, Marc

Total funding

CA$ 1,350,000

Countries

South of Sahara, Nigeria, South Africa

Program

Maternal and Child Health

Project Leader

Gary E. Garber

Project Leader

Alash'le Abimiku

Institution

Institute of Human Virology Nig Ltdgte

Institution Country

Nigeria

Institution Website

http://www.ihvnigeria.org